Quinagolide (INN , BAN ), sold under the brand name Norprolac, is a selective dopamine D2 receptor agonist which is used to reduce elevated levels of prolactin (hyperprolactinemia).[1] It has also been found to be effective in the treatment of breast pain.[2] It is used in the UK, but it is not available in US.
Structure without stereochemistry | |
Clinical data | |
---|---|
Trade names | Norprolac |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C20H33N3O3S |
Molar mass | 395.56 g·mol−1 |
| |
(what is this?) (verify) |
Quinagolide is a racemate composed of the following two enantiomers:[3]
Enantiomeres of Quinagolide | |
---|---|
(+)-Quinagolid CAS number: 140630-79-1 |
(-)-Quinagolid CAS number: 140630-80-4 |